Crossmark

Impact of dose reducing software on patient and staff temple dose during fluoroscopically guided pacemaker insertion, closure devices implantation and coronary angiography procedures

Crossref DOI link: https://doi.org/10.1007/s13246-022-01126-2

Published Online: 2022-05-09

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wilson-Stewart, Kelly S. https://orcid.org/0000-0002-2090-6120
Fontanarosa, Davide https://orcid.org/0000-0001-6986-3718
Malacova, Eva https://orcid.org/0000-0001-5050-8265
Trapp, Jamie V. https://orcid.org/0000-0001-5254-0728
Funding

Funding for this research was provided by:

Queensland University of Technology
License Information

Text and Data Mining valid from 2022-05-09

Version of Record valid from 2022-05-09
More Information

Article History

Received: 21 February 2022

Accepted: 3 April 2022

First Online: 9 May 2022

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below